Found: 106
Select item for more details and to access through your institution.
Targeting ST8SIA6-AS1 counteracts KRAS<sup>G12C</sup> inhibitor resistance through abolishing the reciprocal activation of PLK1/c-Myc signaling.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00466-3
- By:
- Publication type:
- Article
ProNGF promotes brain metastasis through TrkA/EphA2 induced Src activation in triple negative breast cancer cells.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00463-6
- By:
- Publication type:
- Article
The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00464-5
- By:
- Publication type:
- Article
Antitumor effect of a small-molecule inhibitor of KRAS<sup>G12D</sup> in xenograft models of mucinous appendicular neoplasms.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00465-4
- By:
- Publication type:
- Article
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00458-3
- By:
- Publication type:
- Article
Upregulated PARP1 confers breast cancer resistance to CDK4/6 inhibitors via YB-1 phosphorylation.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00462-7
- By:
- Publication type:
- Article
Immune checkpoint inhibitors for multiple myeloma immunotherapy.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00456-5
- By:
- Publication type:
- Article
Deciphering tumor-infiltrating dendritic cells in the single-cell era.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00459-2
- By:
- Publication type:
- Article
Single VHH-directed BCMA CAR-NK cells for multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00461-8
- By:
- Publication type:
- Article
Molecular characterization of the CXCR4 / CXCR7 axis in germ cell tumors and its targetability using nanobody-drug-conjugates.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00460-9
- By:
- Publication type:
- Article
CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00457-4
- By:
- Publication type:
- Article
Downregulation of pro-surfactant protein B contributes to the recurrence of early-stage non-small cell lung cancer by activating PGK1-mediated Akt signaling.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00455-6
- By:
- Publication type:
- Article
The current landscape of using direct inhibitors to target KRAS<sup>G12C</sup>-mutated NSCLC.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00453-8
- By:
- Publication type:
- Article
Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00448-5
- By:
- Publication type:
- Article
New insight into circRNAs: characterization, strategies, and biomedical applications.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00451-w
- By:
- Publication type:
- Article
Targeting CD22 for B-cell hematologic malignancies.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00454-7
- By:
- Publication type:
- Article
Regulatory T cells contribute to the immunosuppressive phenotype of neutrophils in a mouse model of chronic lymphocytic leukemia.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00452-9
- By:
- Publication type:
- Article
CRISPR/Cas9-mediated knockout of intracellular molecule SHP-1 enhances tumor-killing ability of CD133-targeted CAR T cells in vitro.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00450-x
- By:
- Publication type:
- Article
Identification of a novel NPM1 mutation in acute myeloid leukemia.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00449-4
- By:
- Publication type:
- Article
Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00436-9
- By:
- Publication type:
- Article
Correction to: Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00447-6
- By:
- Publication type:
- Article
Targeting and cytotoxicity of chimeric antigen receptor T cells grafted with PD1 extramembrane domain.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00438-7
- By:
- Publication type:
- Article
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00442-x
- By:
- Publication type:
- Article
The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00441-y
- By:
- Publication type:
- Article
Focal adhesion kinase: from biological functions to therapeutic strategies.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00446-7
- By:
- Publication type:
- Article
A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00437-8
- By:
- Publication type:
- Article
Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00445-8
- By:
- Publication type:
- Article
Recent advances and future perspectives in the therapeutics of prostate cancer.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00444-9
- By:
- Publication type:
- Article
Preclinical activity of selinexor in combination with eribulin in uterine leiomyosarcoma.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00443-w
- By:
- Publication type:
- Article
CUL4B-DDB1-COP1-mediated UTX downregulation promotes colorectal cancer progression.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00440-z
- By:
- Publication type:
- Article
Targeting NOTCH1 in combination with antimetabolite drugs prolongs life span in relapsed pediatric and adult T-acute lymphoblastic leukemia xenografts.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00439-6
- By:
- Publication type:
- Article
Elevated expression of the RNA-binding protein IGF2BP1 enhances the mRNA stability of INHBA to promote the invasion and migration of esophageal squamous cancer cells.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00429-8
- By:
- Publication type:
- Article
Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00436-9
- By:
- Publication type:
- Article
Current approaches to develop "off-the-shelf" chimeric antigen receptor (CAR)-T cells for cancer treatment: a systematic review.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00435-w
- By:
- Publication type:
- Article
The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00432-z
- By:
- Publication type:
- Article
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00434-x
- By:
- Publication type:
- Article
Chimeric antigen receptor engineered natural killer cells for cancer therapy.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00431-0
- By:
- Publication type:
- Article
The role of organoids in cancer research.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00433-y
- By:
- Publication type:
- Article
Novel agents and clinical trials in castration-resistant prostate cancer: latest updates from 2023 ASCO-GU Cancers Symposium.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00430-1
- By:
- Publication type:
- Article
Inhibition of CDC20 potentiates anti-tumor immunity through facilitating GSDME-mediated pyroptosis in prostate cancer.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00428-9
- By:
- Publication type:
- Article
Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00426-x
- By:
- Publication type:
- Article
Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00427-w
- By:
- Publication type:
- Article
Construction of CD19 targeted dual- and enhanced dual-antibodies and their efficiency in the treatment of B cell malignancy.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00423-0
- By:
- Publication type:
- Article
DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00413-2
- By:
- Publication type:
- Article
Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00421-2
- By:
- Publication type:
- Article
Fibronectin promotes tumor angiogenesis and progression of non-small-cell lung cancer by elevating WISP3 expression via FAK/MAPK/ HIF-1α axis and activating wnt signaling pathway.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00419-w
- By:
- Publication type:
- Article
Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00422-1
- By:
- Publication type:
- Article
Advances in graft-versus-host disease prevention strategies: latest updates from the 2022 ASH annual meeting.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00425-y
- By:
- Publication type:
- Article
The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00420-3
- By:
- Publication type:
- Article
Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2022 ASH annual meeting.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00424-z
- By:
- Publication type:
- Article